Antibiotics Stewardship in Cesarean Section at a Public Hospital in Surabaya, Indonesia

Fauna Herawati, Rika Yulia, Jihan Binta

Abstract


Cesarean section (CS) is a procedure performed to save the mother and fetus through an incision in the mother’s abdomen and uterus. The high rate of CS in Indonesia correlates with the risk of surgical site infections (SSI), making the use of prophylactic antibiotics important. The use of antibiotics has health impacts on the community, one of which is antibiotic resistance. This study aims to determine antibiotic usage patterns and their compliance with the National Formulary and the Antimicrobial Stewardship Program (PPRA), and the profile of mothers who experience SSI at a public hospital in Surabaya. This retrospective observational quantitative study used medical record data from CS patients from January to June 2024, and the data were analyzed using descriptive statistics and Defined Daily Dose (DDD) methodology to evaluate antibiotic utilization. The results showed cefazolin 2 grams was the most widely used antibiotic (88.64%) with a DDD/100 bed days value of 14.10. Compliance of antibiotic usage patterns with the Antimicrobial Use Guideline (PPAB) reached 88.64%. SSI occurred in 1.31% of patients, especially in pregnancies of more than 2 times. The use of antibiotics at a public hospital in Surabaya is the rational use of antibiotics, the incidence of SSI is smaller than the established standard of 1.5%.


Keywords


antibiotics; cefazolin; cesarean section; DDD/100 bed days; rational antibiotic use; surgical wound infection

Full Text:

PDF

References


Sung S, Mahdy H. Cesarean Section. Vet Tech Llamas Alpacas, Second Ed [Internet]. 2023 Jul 9 [cited 2024 Aug 2]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK546707/

Betran AP, Torloni MR, Zhang JJ, Gülmezoglu AM; WHO Working Group on Caesarean Section. WHO statement on caesarean section rates. BJOG. 2016;123(5):667–70.

Ministry of Health Republic Indonesia. Basic Health Research 2018. National Institute of Health Research and Development. 2018. p. 156.

Verma V, Vishwakarma RK, Nath DC, Khan HTA, Prakash R, Abid O. Prevalence and Determinants of Caesarean Section in South and South-East Asian Women. PloS One. 2020;15(3):e0229906.

Morikane K, Russo PL, Lee KY, Chakravarthy M, Ling ML, Saguil E, et al. Expert Commentary on the Challenges and Opportunities for Surgical Site Infection Prevention Through Implementation of Evidence-Based Guidelines in The Asia-Pacific Region. 2021;10:65.

Liu R, Lin L, Wang D. Antimicrobial Prophylaxis in Caesarean Section Delivery. Exp Ther Med. 2016;12(2):961–4.

Pan DST, Huang JH, Lee MHM, Yu Y, Chen MIC, Goh EH, et al. Knowledge, Attitudes, and Practices Towards Antibiotic use in Upper Respiratory Tract Infections among Patients Seeking Primary Health Care in Singapore. BMC Fam Pract. 2016;17:148.

Amaha ND, Weldemariam DG, Berhe YH. Antibiotic Consumption Study in Two Hospitals in Asmara from 2014 to 2018 using WHO’s Defined Daily Dose (DDD) Methodology. PLoS One. 2020;15(7):e0233275.

Negese K, Belachew DZ. Maternal complications and associated factors among mothers who underwent a cesarean section at Gebretsadik Shewa general hospital: an institution based cross-sectional study. Front Glob Womens Health. 2023;4:1091863.

Baharuddin M, Amelia D, Suhowatsky S, Kusuma A, Suhargono MH, Eng B. Maternal death reviews: A retrospective case series of 90 hospital‐based maternal deaths in 11 hospitals in Indonesia. Int J Gynecol Obstet. 2019;144 Suppl 1:59–64.

Banayan J, Rana S, Mueller A, Tung A, Ramadan H, Arany Z, et al. Cardiogenic shock in pregnancy: Analysis from the National Inpatient Sample. Hypertens Pregnancy. 2017;36(2):117–23.

Thirunavukkarausu S, Chinnappa P, Kaliamoorthi A. Efficacy of Extended Antibiotic Prophylaxis with Azithromycin in Cesarean Sections. J Pharm Bioallied Sci. 2024;16(Suppl 4):S3370–3.

Brahmana A. Tjokroprawiro, Muhammad I. A. Akbar, Renata A. Ulhaq, Indra Yuliati, Muhammad Yusuf, Budi Prasetyo. Antibiotic Use in Caesarean Section among Obstetricians and Gynaecologists in the Second Largest City in Indonesia. Indones J Obstet Gynecol. 2023;80–6.

Elkomy MH, Sultan P, Drover DR, Epshtein E, Galinkin JL, Carvalho B. Pharmacokinetics of prophylactic cefazolin in parturients undergoing cesarean delivery. Antimicrob Agents Chemother. 2014;58(6):3504–13.

Markwei MT, Babatunde I, Rathi N, Fan C, Prah MA, Joo J, et al. Preincision adjunctive prophylaxis for cesarean deliveries a systematic review and meta-analysis. Am J Obstet Gynecol. 2021;225(4):382.e1-382.e13.

Apriyanti YF, Saepudin. Review: application of the ATC/DDD method for antibiotic evaluation in Indonesia. Medical Sains: Jurnal Ilmiah Kefarmasian; 2023: 8(3), 1323–44.

Cohen G, Schreiber H, Amer Y, Shalev-Ram H, Eliner O, Biron-Shental T, Kovo M. The effectiveness of a cesarean delivery bundle with vaginal preparation, cefazolin, and azithromycin in reducing postoperative infections: A before-and-after study. Int J Gynaecol Obstet. 2025;170(1):448–55.

Zejnullahu VA, Zejnullahu VA, Isjanovska R, Sejfija Z. Surgical site infections after cesarean sections at the University Clinical Center of Kosovo: Rates, microbiological profile and risk factors. BMC Infect Dis. 2019;19(1):752.

Kartikasari R, Apriningrum N. Post Sectio Caesarea Determinants of Post Caesarean Section Surgical Site Infection (SSI). Faletehan Heal J. 2020;7(3):162–9.

Jabbar S, Perveen S, Naseer Q. Surgical Site Infection (SSI): Frequency and Risk Factors in Post Caesarean Section Cases in a Tertiary Care Hospital. ASH & KMDC. 2016;21(4):233.

Gach MW, Lazarus G, Simadibrata DM, Sinto R, Saharman YR, Limato R, et al. Antimicrobial resistance among common bacterial pathogens in Indonesia: a systematic review. Lancet Reg Heal Southeast Asia. 2024;26:100414.




DOI: https://doi.org/10.15416/ijcp.2025.v14i3.63748

Refbacks

  • There are currently no refbacks.


 Indonesian Journal of Clinical Pharmacy is indexed by

        

  Creative Commons License

IJCP by Universitas Padjadjaran is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 

View My Stats